BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 17878748)

  • 1. Transcriptional upregulation of breast cancer resistance protein by 17beta-estradiol in ERalpha-positive MCF-7 breast cancer cells.
    Zhang Y; Zhou G; Wang H; Zhang X; Wei F; Cai Y; Yin D
    Oncology; 2006; 71(5-6):446-55. PubMed ID: 17878748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Regulation mechanism of breast cancer resistance protein by toremifene to reverse BCRP-mediated multidrug resistance in breast cancer cells].
    Zhang YH; Li G; Yu J; Xu MS; Liu ZX
    Zhonghua Zhong Liu Za Zhi; 2011 Sep; 33(9):654-60. PubMed ID: 22340044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional modulation of BCRP gene to reverse multidrug resistance by toremifene in breast adenocarcinoma cells.
    Zhang Y; Wang H; Wei L; Li G; Yu J; Gao Y; Gao P; Zhang X; Wei F; Yin D; Zhou G
    Breast Cancer Res Treat; 2010 Oct; 123(3):679-89. PubMed ID: 19967559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen-mediated post transcriptional down-regulation of breast cancer resistance protein/ABCG2.
    Imai Y; Ishikawa E; Asada S; Sugimoto Y
    Cancer Res; 2005 Jan; 65(2):596-604. PubMed ID: 15695404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Harmful effect of ERβ on BCRP-mediated drug resistance and cell proliferation in ERα/PR-negative breast cancer.
    Li W; Jia M; Qin X; Hu J; Zhang X; Zhou G
    FEBS J; 2013 Dec; 280(23):6128-40. PubMed ID: 24103091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
    Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
    Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progesterone receptor downregulates breast cancer resistance protein expression via binding to the progesterone response element in breast cancer.
    Wu X; Zhang X; Zhang H; Su P; Li W; Li L; Wang Y; Liu W; Gao P; Zhou G
    Cancer Sci; 2012 May; 103(5):959-67. PubMed ID: 22348324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a novel estrogen response element in the breast cancer resistance protein (ABCG2) gene.
    Ee PL; Kamalakaran S; Tonetti D; He X; Ross DD; Beck WT
    Cancer Res; 2004 Feb; 64(4):1247-51. PubMed ID: 14973083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of BCRP/ABCG2 expression by progesterone and 17beta-estradiol in human placental BeWo cells.
    Wang H; Zhou L; Gupta A; Vethanayagam RR; Zhang Y; Unadkat JD; Mao Q
    Am J Physiol Endocrinol Metab; 2006 May; 290(5):E798-807. PubMed ID: 16352672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proinflammatory cytokines enhance estrogen-dependent expression of the multidrug transporter gene ABCG2 through estrogen receptor and NF{kappa}B cooperativity at adjacent response elements.
    Pradhan M; Bembinster LA; Baumgarten SC; Frasor J
    J Biol Chem; 2010 Oct; 285(41):31100-6. PubMed ID: 20705611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survivin up-regulates the expression of breast cancer resistance protein (BCRP) through attenuating the suppression of p53 on NF-κB expression in MCF-7/5-FU cells.
    Wang QP; Wang Y; Wang XD; Mo XM; Gu J; Lu ZY; Pan ZL; Zhu YX
    Int J Biochem Cell Biol; 2013 Sep; 45(9):2036-44. PubMed ID: 23838170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cooperative effect of gefitinib and fumitremorgin c on cell growth and chemosensitivity in estrogen receptor alpha negative fulvestrant-resistant MCF-7 cells.
    Liu H; Cheng D; Weichel AK; Osipo C; Wing LK; Chen B; Louis TE; Jordan VC
    Int J Oncol; 2006 Nov; 29(5):1237-46. PubMed ID: 17016657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel 5' untranslated region variants of BCRP mRNA are differentially expressed in drug-selected cancer cells and in normal human tissues: implications for drug resistance, tissue-specific expression, and alternative promoter usage.
    Nakanishi T; Bailey-Dell KJ; Hassel BA; Shiozawa K; Sullivan DM; Turner J; Ross DD
    Cancer Res; 2006 May; 66(10):5007-11. PubMed ID: 16707421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Up-regulation of LRP16 mRNA by 17beta-estradiol through activation of estrogen receptor alpha (ERalpha), but not ERbeta, and promotion of human breast cancer MCF-7 cell proliferation: a preliminary report.
    Han WD; Mu YM; Lu XC; Xu ZM; Li XJ; Yu L; Song HJ; Li M; Lu JM; Zhao YL; Pan CY
    Endocr Relat Cancer; 2003 Jun; 10(2):217-24. PubMed ID: 12790785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2).
    Doyle L; Ross DD
    Oncogene; 2003 Oct; 22(47):7340-58. PubMed ID: 14576842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-181a enhances drug sensitivity in mitoxantone-resistant breast cancer cells by targeting breast cancer resistance protein (BCRP/ABCG2).
    Jiao X; Zhao L; Ma M; Bai X; He M; Yan Y; Wang Y; Chen Q; Zhao X; Zhou M; Cui Z; Zheng Z; Wang E; Wei M
    Breast Cancer Res Treat; 2013 Jun; 139(3):717-30. PubMed ID: 23780685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional cyclic AMP response element in the breast cancer resistance protein (BCRP/ABCG2) promoter modulates epidermal growth factor receptor pathway- or androgen withdrawal-mediated BCRP/ABCG2 transcription in human cancer cells.
    Xie Y; Nakanishi T; Natarajan K; Safren L; Hamburger AW; Hussain A; Ross DD
    Biochim Biophys Acta; 2015 Mar; 1849(3):317-27. PubMed ID: 25615818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and functional analyses of breast cancer resistance protein in lung cancer.
    Kawabata S; Oka M; Soda H; Shiozawa K; Nakatomi K; Tsurutani J; Nakamura Y; Doi S; Kitazaki T; Sugahara K; Yamada Y; Kamihira S; Kohno S
    Clin Cancer Res; 2003 Aug; 9(8):3052-7. PubMed ID: 12912956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progesterone negatively regulates BCRP in progesterone receptor-positive human breast cancer cells.
    Wu X; Zhang X; Sun L; Zhang H; Li L; Wang X; Li W; Su P; Hu J; Gao P; Zhou G
    Cell Physiol Biochem; 2013; 32(2):344-54. PubMed ID: 23988382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BCRP at the blood-brain barrier: genomic regulation by 17β-estradiol.
    Mahringer A; Fricker G
    Mol Pharm; 2010 Oct; 7(5):1835-47. PubMed ID: 20735085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.